BioHealth News Archive
Strategies in uncertainty: How best to expand our licensed nurse aide workforce – Guest columns – McKnight’s Long-Term Care News
The U.S. Department of Health and Human Services declared a Public Health Emergency (PHE) in response to the COVID-19 pandemic on January 31, 2020.…
Read MoreEarly Charm Announces Doubling of Production and Development Space at Baltimore’s 1100 Wicomico
November 2, 2021, Baltimore, MD – In a move to accommodate its continued fast growth, Early Charm – a company that creates, owns and…
Read MoreMaryland on track to surpass $2B in VC funding this year
By Giacomo Bologna November 03, 2021, Maryland is on track to top $2 billion worth of venture capital deals in 2021, its highest ever…
Read MoreThese Countries Have The Most Startup Investment For Their Size – Crunchbase News
Among the world’s largest nations, the U.S. has by far the highest rate of startup investment relative to population. Over the past year, venture…
Read MoreRecord Funding Invested in Montgomery County, Maryland Companies in 2021 Q1-Q3 — MCEDC
Rockville, Md. — Thus far in 2021, a record pace for initial public offerings (IPO), private investment and venture capital deals has been set…
Read MoreSix Up-and-Coming COVID-19 Vaccines
Since the start of the COVID-19 pandemic, the response from public health agencies, regulators, researchers, and industry has been dominated by the development of…
Read MoreGaitherburg’s Adaptive Phage Therapeutics Announces Strategic Agreement with ARLG to Support Phase 1b/2 Cystic Fibrosis Study
GAITHERSBURG, MD, November 2, 2021 – Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today…
Read MoreBHI EIR Feedback Day November 17th. Register Now!
Are you a biohealth start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your…
Read MoreJuneBrain Moves to UM BioPark for Next Growth Phase | UM BioPark
BALTIMORE, MD, OCT. 29, 2021 – The University of Maryland BioPark (UM BioPark) today announced that JuneBrain Inc., a telehealth device company that empowers…
Read MoreBioTalk Welcomes Amritha Jaishankar, PhD, Executive Director, Maryland Stem Cell Research Fund (MSCRF)
Amritha Jaishankar, PhD, Executive Director, Maryland Stem Cell Research Fund (MSCRF), joins BioTalk to discuss her career, investing in Maryland, and accelerating cures. …
Read MoreMaxCyte Signs Strategic Platform License with Nkarta, Inc. to Advance Natural Killer Cell Therapy Programs
Nkarta to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to accelerate the development of its oncology cell-therapy candidates SOUTH SAN FRANCISCO and…
Read MoreFour Ways Quantum Computing Could Change The World
Organizations and governments around the world are pouring billions of dollars into quantum research and development, with the likes of Google, Microsoft and Intel racing…
Read MoreMaryland Commerce Launches Maryland Innovation Investment Tax Credit – The Southern Maryland Chronicle
BALTIMORE, MD (October 26, 2021) — The Maryland Department of Commerce has launched the Maryland Innovation Investment Tax Credit, which will help foster the…
Read MoreCatalent’s Investment in Expanding its State-of-the-Art Gene Therapy Commercial Manufacturing Campus in Harmans, Maryland, Increases to $360M
SOMERSET, N.J. – October 26, 2021 — Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch,…
Read MoreNovavax files for authorization of Covid-19 vaccine in UK – Washington Business Journal
Novavax Inc. (NASDAQ: NVAX) has filed for regulatory approval of its Covid-19 vaccine candidate in the U.K. — a major step toward seeking approval…
Read More